Cellular Oncology

Article	Citations
CoQ10 reduces glioblastoma growth and infiltration through proteome remodeling and inhibition of angiogenesis and inflammation	86
Publisher Correction to: RAB37 suppresses the EMT, migration and invasion of gastric cancer cells by mediating autophagic degradation of β-catenin	66
Asymmetric post-translational modifications regulate the nuclear translocation of STAT3 homodimers in response to leukemia inhibitory factor	62
Dissecting the single-cell transcriptome network of macrophage and identifies a signature to predict prognosis in lung adenocarcinoma	57
HNRNPH1 stabilizes FLOT2 mRNA in a non-canonical m6A-dependent manner to promote malignant progression in nasopharyngeal carcinoma	54
Methionine-producing tumor micro(be) environment fuels growth of solid tumors	51
The therapeutic potential of exosomes in lung cancer	45
Deciphering the molecular landscape: evolutionary progression from gynecomastia to aggressive male breast cancer	45
Pyrotinib inhibits the tumorigenicity of HER2-positive non-small cell lung cancer by inducing ARIH1/ubiquitin/lysosome-dependent degradation of HER2	43
Pathways and outputs orchestrated in tumor microenvironment cells by hypoxia-induced tumor-derived exosomes in pan-cancer	39
Loss of histone deubiquitinase Bap1 triggers anti-tumor immunity	38
Application of circulating tumour cells to predict response to treatment in head and neck cancer	38
Molecular mechanisms underlying the action of carcinogens in gastric cancer with a glimpse into targeted therapy	38
Proteomic characterisation of prostate cancer intercellular communication reveals cell type-selective signalling and TMSB4X-dependent fibroblast reprogramming	37
Ubiquilin-4 induces immune escape in gastric cancer by activating the notch signaling pathway	36
Targeting nucleolin improves sensitivity to chemotherapy in acute lymphoblastic leukemia	34
FSCN1 induced PTPRF-dependent tumor microenvironment inflammatory reprogramming promotes lung adenocarcinoma progression via regulating macrophagic glycolysis	31
RAB37 suppresses the EMT, migration and invasion of gastric cancer cells by mediating autophagic degradation of β-catenin	31
TRPV4 drives the progression of leiomyosarcoma by promoting ECM1 generation and co-activating the FAK/PI3K/AKT/GSK3β pathway	29
In vivo study revealed pro-tumorigenic effect of CMTM3 in hepatocellular carcinoma involving the regulation of peroxisome proliferator-activated receptor gamma (PPARγ)	27
Exploring the impact of PDGFD in osteosarcoma metastasis through single-cell sequencing analysis	26
OSW-1 induces apoptosis and cyto-protective autophagy, and synergizes with chemotherapy on triple negative breast cancer metastasis	25
High-plex spatial transcriptomic profiling reveals distinct immune components and the HLA class I/DNMT3A/CD8 modulatory axis in mismatch repair-deficient endometrial cancer	25
RETRACTED ARTICLE: The autocrine glycosylated-GREM1 interacts with TGFB1 to suppress TGFβ/BMP/SMAD-mediated EMT partially by inhibiting MYL9 transactivation in urinary carcinoma	25
Neuregulin-induced HER3 activation drives migration in head and neck squamous cell carcinoma via HER2 and FAK signaling pathways	25

Trends in immunotherapy for oral squamous cell carcinoma	25
SUMOylation inhibitors activate anti-tumor immunity by reshaping the immune microenvironment in a preclinical model of hepatocellular carcinoma	24
Next-generation BCMA-targeted chimeric antigen receptor CARTemis-1: the impact of manufacturing procedure on CAR T-cell features	23
RRM2 as a novel prognostic and therapeutic target of NF1-associated MPNST	22
Dual anti-angiogenic and anti-metastatic activity of myriocin synergistically enhances the anti-tumor activity of cisplatin	22
Neuropilin-2 acts a critical determinant for epithelial-to-mesenchymal transition and aggressive behaviors of human head and neck cancer	22
Correction to: 3D bioprinted tumor model: a prompt and convenient platform for overcoming immunotherapy resistance by recapitulating the tumor microenvironment	21
TBX21 attenuates colorectal cancer progression via an ARHGAP29/RSK/GSK3β dependent manner	21
Aberrant expression of circular RNA DHPR facilitates tumor growth and metastasis by regulating the RASGEF1B/RAS/MAPK axis in hepatocellular carcinoma	21
OrganoIDNet: a deep learning tool for identification of therapeutic effects in PDAC organoid-PBMC co-cultures from time-resolved imaging data	20
The survival prediction analysis and preliminary study of the biological function of YEATS2 in hepatocellular carcinoma	20
Spheroid-induced heterogeneity and plasticity of uveal melanoma cells	20
TRIM28 promotes tumor growth and metastasis in breast cancer by targeting the BRD7 protein for ubiquitination and degradation	20
Modulation of miR-146b by N6-methyladenosine modification remodels tumor-associated macrophages and enhances anti-PD-1 therapy in colorectal cancer	19
Exosomes: a potential diagnostic and treatment modality in the quest for counteracting cancer	19
Dipyridamole enhances the anti-cancer ability of aspirin against colorectal cancer by inducing apoptosis in an unfolded protein response-dependent manner	19
USP28 promotes tumor progression and glycolysis by stabilizing PKM2/Hif1-α in cholangiocarcinoma	19
Ezrin accelerates breast cancer liver metastasis through promoting furin-like convertase-mediated cleavage of Notch1	19
From basic research to clinical application: targeting fibroblast activation protein for cancer diagnosis and treatment	18
Emerging roles of deubiquitinating enzymes in actin cytoskeleton and tumor metastasis	18
Osteopontin secreted from obese adipocytes enhances angiogenesis and promotes progression of pancreatic ductal adenocarcinoma in obesity	18
Feature-weight based measurement of cancerous transcriptome using cohort-wide and sample-specific information	18
Prognostic significance of collagen signatures at breast tumor boundary obtained by combining multiphoton imaging and imaging analysis	18
Extracellular vesicles related gene HSPH1 exerts anti-tumor effects in prostate cancer via promoting the stress response of CD8 + T cells	18
Silencing AHNAK promotes nasopharyngeal carcinoma progression by upregulating the ANXA2 protein	18
Cancer/testis-45A1 promotes cervical cancer cell tumorigenesis and drug resistance by activating oncogenic SRC and downstream signaling pathways	18
Small extracellular vesicles promote invadopodia activity in glioblastoma cells in a therapy-dependent manner	18
The PPP2R1A cancer hotspot mutant p.R183W increases clofarabine resistance in uterine serous carcinoma cells by a gain-of-function mechanism	17
RAB3A-mediated BAG6 translocation promotes non-small cell lung cancer tumorigenesis and progression	17
Lactylation: the regulatory code of cellular life activity and a barometer of diseases	17
Integrated analysis of single-cell RNA-seq and bulk RNA-seq reveals immune suppression subtypes and establishes a novel signature for determining the prognosis in lung adenocarcinoma	17
The composition and roles of gastric stem cells in epithelial homeostasis, regeneration, and tumorigenesis	16
Non-coding RNA regulation of integrins and their potential as therapeutic targets in cancer	16
Retraction Note: TRAIL enhances quinacrine-mediated apoptosis in breast cancer cells through induction of autophagy via modulation of p21 and DR5 interactions	16
Targeting the Notch-Furin axis with 2-hydroxyoleic acid: a key mechanism in glioblastoma therapy	16
PAQR5 inhibits the growth and metastasis of clear cell renal cell carcinoma by suppressing the JAK/STAT3 signaling pathway	16
Upregulated NNMT sustains angiogenesis in clear cell renal cell carcinoma through activation of the SDF-1/CXCR4–ERK–CCL20 axis	16
Targeting CSPG4 enhances the anti-tumor activity of CAR-NK cells for glioblastoma	16
HDAC6: A unique HDAC family member as a cancer target	16
Targeting MEK/COX-2 axis improve immunotherapy efficacy in dMMR colorectal cancer with PIK3CA overexpression	16
Iron metabolism in colorectal cancer: a balancing act	16
Lenalidomide overcomes the resistance to third-generation CD19-CAR-T cell therapy in preclinical models of diffuse large B-cell lymphoma	16
Integrating multi-modal transcriptomics identifies cellular subtypes with distinct roles in PDAC progression	16
Vimentin promotes glioma progression and maintains glioma cell resistance to oxidative phosphorylation inhibition	15
Cancer-associated fibroblast-derived extracellular vesicles facilitate metastasis in hepatocellular carcinoma by delivering CTGF	15
RACK1 attenuates pancreatic tumorigenesis by suppressing acinar-to-ductal metaplasia through inflammatory signaling modulation	15
Distinct tumor microenvironment landscapes of rectal cancer for prognosis and prediction of immunotherapy response	15
Role of ELMO1 in inflammation and cancer—clinical implications	15
circRNA_0067717 promotes paclitaxel resistance in nasopharyngeal carcinoma by acting as a scaffold for TRIM41 and p53	15
HBO1 determines epithelial-mesenchymal transition and promotes immunotherapy resistance in ovarian cancer cells	15

Non-glycanated ΔDCN isoform in muscle invasive bladder cancer mediates cancer stemness and gemcitabine resistance	15
HVEM in acute lymphocytic leukemia facilitates tumour immune escape by inhibiting CD8+ T cell function	15
Integrated approach to functional analysis of an ERBB2 variant of unknown significance detected by a cancer gene panel test	14
Cell death in glioblastoma and the central nervous system	14
GDF15 induces chemoresistance to oxaliplatin by forming a reciprocal feedback loop with Nrf2 to maintain redox homeostasis in colorectal cancer	14
DNA-methylome-derived epigenetic fingerprint as an immunophenotype indicator of durable clinical immunotherapeutic benefits in head and neck squamous cell carcinoma	14
Low-dose SAHA enhances CD8+ T cell-mediated antitumor immunity by boosting MHC I expression in non-small cell lung cancer	14
Characterization and proteomic analysis of plasma-derived small extracellular vesicles in locally advanced rectal cancer patients	14
Nilotinib in combination with sunitinib renders MCL-1 for degradation and activates autophagy that overcomes sunitinib resistance in renal cell carcinoma	14
Marine derived macrolide bryostatin 4 inhibits the TGF-β signaling pathway against acute erythroleukemia	14
Microbial metabolite trimethylamine-N-oxide induces intestinal carcinogenesis through inhibiting farnesoid X receptor signaling	13
AKT inhibition sensitizes EVI1 expressing colon cancer cells to irinotecan therapy by regulating the Akt/mTOR axis	13
Tumour-derived exosomal lncRNA SNHG16 induces telocytes to promote metastasis of hepatocellular carcinoma via the miR-942-3p/MMP9 axis	13
Tumor-infiltrating myeloid cells; mechanisms, functional significance, and targeting in cancer therapy	13
ADAR1 enhances tumor proliferation and radioresistance in non-small cell lung cancer by interacting with Rad18	13
Antitumor activity of afatinib in EGFR T790M-negative human oral cancer therapeutically targets mTOR/Mcl-1 signaling axis	13
Therapeutic exosomes loaded with SERPINA5 attenuated endometrial cancer cell migration via the integrin β1/FAK signaling pathway	13
E3 ubiquitin ligases in cancer stem cells: key regulators of cancer hallmarks and novel therapeutic opportunities	13
Trained immunity alleviates the progression of melanoma during sepsis-associated immunoparalysis	13
Targeting TRIM24 promotes neuroblastoma differentiation and decreases tumorigenicity via LSD1/CoREST complex	13
Mapping the immune terrain in lung adenocarcinoma progression: Tfh-like cells in tertiary lymphoid structures	13
Targeting human mitochondrial NAD(P)+-dependent malic enzyme (ME2) impairs energy metabolism and redox state and exhibits antileukemic activity in acute myeloid leukemia	13
Plasma cell signatures predict prognosis and treatment efficacy for lung adenocarcinoma	13
Publisher Correction to: RETRACTED ARTICLE: Human bone marrow-derived mesenchymal stem cell-secreted exosomes overexpressing microRNA-34a ameliorate glioblastoma development via down-regulating MYCN	13
Hippocalcin-like 1 is a key regulator of LDHA activation that promotes the growth of non-small cell lung carcinoma	13
LncRNA MIR4435-2HG drives cancer progression by modulating cell cycle regulators and mTOR signaling in stroma-enriched subtypes of urothelial carcinoma of the bladder	12
Integrating bulk and single-cell transcriptomics to elucidate the role and potential mechanisms of autophagy in aging tissue	12
Identification of a novel gene signature related to prognosis and metastasis in gastric cancer	12
Lactate score classification of hepatocellular carcinoma helps identify patients with tumors that respond to immune checkpoint blockade therapy	12
Host-derived growth factors drive ERK phosphorylation and MCL1 expression to promote osteosarcoma cell survival during metastatic lung colonization	12
Stiffened tumor microenvironment enhances perineural invasion in breast cancer via integrin signaling	12
VE-822 upregulates the deubiquitinase OTUD1 to stabilize FHL1 to inhibit the progression of lung adenocarcinoma	12
DNASE1L3 inhibits hepatocellular carcinoma by delaying cell cycle progression through CDK2	12
The m1A-SFRP2-NFAT/TOX axis governs T cell exhaustion in gastric cancer	11
Interferon Gamma Inducible Protein 30: from biological functions to potential therapeutic target in cancers	11
Spatiotemporal modulation of SMAD4 by HBx is required for cellular proliferation in hepatitis B-related liver cancer	11
Inhibition of PP2A by LB100 sensitizes bladder cancer cells to chemotherapy by inducing p21 degradation	11
Expression of the zinc-finger transcription factor Osterix (SP7) in invasive breast cancer and its prognostic significance	11
Senolytics: charting a new course or enhancing existing anti-tumor therapies?	11
Triggering immunogenic death of cancer cells by nanoparticles overcomes immunotherapy resistance	11
ABCA6 affects the malignancy of Ewing sarcoma cells via cholesterol-guided inhibition of the IGF1R/AKT/MDM2 axis	11
Integrative proteomics and n-glycoproteomics reveal the synergistic anti-tumor effects of aspirin- and gemcitabine-based chemotherapy on pancreatic cancer cells	11
Crosstalk between oxidative phosphorylation and immune escape in cancer: a new concept of therapeutic targets selection	11
Roles of NRF2 in DNA damage repair	11
Identifying the effectiveness of 3D culture systems to recapitulate breast tumor tissue in situ	11
Genomic diversity and BCL9L mutational status in circulating tumor cells predict overall survival in metastatic colorectal cancer	11
Allelic expression imbalance of CDKN2A variants in childhood acute lymphoblastic leukemia	11
RCN2 promotes Nasopharyngeal carcinoma progression by curbing Calcium flow and Mitochondrial apoptosis	10
Crosstalk between long noncoding RNA and microRNA in Cancer	10
TRIM44 regulates tumor immunity in gastric cancer through LOXL2-dependent extracellular matrix remodeling	10
Correction to: CoQ10 reduces glioblastoma growth and infiltration through proteome remodeling and inhibition of angiogenesis and inflammation	10
Molecular signaling in pancreatic ductal metaplasia: emerging biomarkers for detection and intervention of early pancreatic cancer	10
Low-dose anti-VEGFR2 therapy promotes anti-tumor immunity in lung adenocarcinoma by down-regulating the expression of layilin on tumor-infiltrating CD8+T cells	10
Fibroblast subtypes in pancreatic cancer and pancreatitis: from mechanisms to therapeutic strategies	10
Deciphering fatty acid biosynthesis-driven molecular subtypes in pancreatic ductal adenocarcinoma with prognostic insights	10
IFIT1 modulates the proliferation, migration and invasion of pancreatic cancer cells via Wnt/β-catenin signaling	10
Correction to: ABCA6 affects the malignancy of Ewing sarcoma cells via cholesterol-guided inhibition of the IGF1R/AKT/MDM2 axis	10
CircGLIS3 inhibits thyroid cancer invasion and metastasis through miR-146b-3p/AIF1L axis	10
Cholesterol homeostasis and cancer: a new perspective on the low-density lipoprotein receptor	10
miR-4739 promotes epithelial-mesenchymal transition and angiogenesis in “driver gene-negative” non-small cell lung cancer via activating the Wnt/β-catenin signaling	10
Soluble TGFBI aggravates the malignancy of cholangiocarcinoma through activation of the ITGB1 dependent PPARγ signalling pathway	9
Nucleotide sugar transporter SLC35A2 is involved in promoting hepatocellular carcinoma metastasis by regulating cellular glycosylation	9
METTL3 suppresses pancreatic ductal adenocarcinoma progression through activating endogenous dsRNA-induced anti-tumor immunity	9
Correction to: IDH2, a novel target of OGT, facilitates glucose uptake and cellular bioenergy production via NF-κB signaling to promote colorectal cancer progression	9
Proteasomal deubiquitylase activity enhances cell surface recycling of the epidermal growth factor receptor in non-small cell lung cancer	9
Efficacy of CDK4/6 Inhibition in colorectal cancer and the role of p16 expression in predicting drug resistance	9
Establishment, characterization, and biobanking of 36 pancreatic cancer organoids: prediction of metastasis in resectable pancreatic cancer	9
Exploring tumor microenvironment interactions and apoptosis pathways in NSCLC through spatial transcriptomics and machine learning	9
Non-canonical role for the ataxia-telangiectasia-Rad3 pathway in STAT3 activation in human multiple myeloma cells	9
Unraveling Th subsets: insights into their role in immune checkpoint inhibitor therapy	9
Enhanced ZBTB10 expression induced by betulinic acid inhibits gastric cancer progression by inactivating the ARRDC3/ITGB4/PI3K/AKT pathway	9
Discovery of a small molecule ligand of FRS2 that inhibits invasion and tumor growth	9
Inhibition of thioredoxin-1 enhances the toxicity of glycolysis inhibitor 2-deoxyglucose by downregulating SLC1A5 expression in colorectal cancer cells	9
Role of nerves in neurofibromatosis type 1-related nervous system tumors	9
Loss of RACK1 promotes glutamine addiction via activating AKT/mTOR/ASCT2 axis to facilitate tumor growth in gastric cancer	9
EGFR blockade confers sensitivity to pan-RAS inhibitors in KRAS-mutated cancers	9
Single-cell RNA profiling identifies diverse cellular responses to EWSR1/FLI1 downregulation in Ewing sarcoma cells	9
Discoidin domain receptor 1 promotes hepatocellular carcinoma progression through modulation of SLC1A5 and the mTORC1 signaling pathway	9
Thymidine kinase 1 indicates resistance to immune checkpoint plus tyrosine kinase inhibition in renal cell carcinoma	8
Novel insights into lncRNAs as key regulators of post-translational modifications in cancer: mechanisms and therapeutic potential	8

The multi-kinase inhibitor afatinib serves as a novel candidate for the treatment of human uveal melanoma	8
From benign neurofibromas to malignant peripheral nerve sheath tumors (MPNST): a gaming among multiple factors	8
Machine learning constructs a ferroptosis related signature for predicting prognosis and drug sensitivity in lung cancer	8
In-depth quantitative proteomics analysis revealed C1GALT1 depletion in ECC-1 cells mimics an aggressive endometrial cancer phenotype observed in cancer patients with low C1GALT1 expression	8
Targeting CA9 restricts pancreatic cancer progression through pH regulation and ROS production	8
Comprehensive analysis of clinical prognostic features and tumor microenvironment landscape of CD11b+CD64+ patients with acute myeloid leukemia	8
Activation of the HSP27-AKT axis contributes to gefitinib resistance in non-small cell lung cancer cells independent of EGFR mutations	8
The Ribonuclease ZC3H12A is required for self-inflicted DNA breaks after DNA damage in small cell lung cancer cells	8
Heterogeneity, inherent and acquired drug resistance in patient-derived organoid models of primary liver cancer	8
Correction to: CCL18 secreted from M2 macrophages promotes migration and invasion via the PI3K/Akt pathway in gallbladder cancer	8
LILRB2 promotes immune escape in breast cancer cells via enhanced HLA-A degradation	8
High extracellular matrix stiffness upregulates TNNT1 to awaken dormant tumor cells in liver metastatic niches of gastric cancer	8
STK3 kinase activation inhibits tumor proliferation through FOXO1-TP53INP1/P21 pathway in esophageal squamous cell carcinoma	8
VHL and DNA damage repair pathway alterations as potential clinical biomarkers for first-line TKIs in metastatic clear cell renal cell carcinomas	8
The SLITRK4-CNPY3 axis promotes liver metastasis of gastric cancer by enhancing the endocytosis and recycling of TrkB in tumour cells	8
Dual blockage of P-cadherin and c-Met synergistically inhibits the growth of head and neck cancer	8
Retraction Note: Downregulation of beta-catenin in chemo-tolerant TNBC through changes in receptor and antagonist profiles of the WNT pathway: Clinical and prognostic implications	8
A review on the functional characteristics of the c-Myeloproliferative Leukaemia (c-MPL) gene and its isoforms	8
Triggering pyroptosis enhances the antitumor efficacy of PARP inhibitors in prostate cancer	8
SPG21, a potential oncogene targeted by miR-128-3p, amplifies HBx-induced carcinogenesis and chemoresistance via activation of TRPM7-mediated JNK pathway in hepatocellular carcinoma	7
FBXO32 targets PHPT1 for ubiquitination to regulate the growth of EGFR mutant lung cancer	7
Embracing cancer immunotherapy with manganese particles	7
Presence of regulatory T-cells in endometrial cancer predicts poorer overall survival and promotes progression of tumor cells	7
Fasting in combination with the cocktail Sorafenib:Metformin blunts cellular plasticity and promotes liver cancer cell death via poly-metabolic exhaustion	7
Dysregulation of the p53 pathway provides a therapeutic target in aggressive pediatric sarcomas with stem-like traits	7
Correction to: Colorectal cancer organoid models uncover oxaliplatin-resistant mechanisms at single cell resolution	7
A novel risk score system based on immune subtypes for identifying optimal mRNA vaccination population in hepatocellular carcinoma	7
Fbxo2 inhibits cell proliferation, migration and invasion by the ubiquitin-mediated degradation of WEE1 in renal cell carcinoma	7
NK cells as powerful therapeutic tool in cancer immunotherapy	7
Non-canonical function of PHGDH promotes HCC metastasis by interacting with METTL3	7
DNA hypomethylation patterns and their impact on the tumor microenvironment in colorectal cancer	7
Retraction Note: Leptin promotes the migration and invasion of breast cancer cells by upregulating ACAT2	7
Genomic analysis and filtration of novel prognostic biomarkers based on metabolic and immune subtypes in pancreatic cancer	7
CEP55 3’-UTR promotes epithelial–mesenchymal transition and enhances tumorigenicity of bladder cancer cells by acting as a ceRNA regulating miR-497-5p	7
TIMEAS, a promising method for the stratification of testicular germ cell tumor patients with distinct immune microenvironment, clinical outcome and sensitivity to frontline therapies	7
Effect of infiltrating immune cells in tumor microenvironment on metastasis of hepatocellular carcinoma	7
Mitochondria in tumor immune surveillance and tumor therapies targeting mitochondria	7
Three-dimensional genome architecture in intrahepatic cholangiocarcinoma	7
Therapeutic effects against high-grade glioblastoma mediated by engineered induced neural stem cells combined with GD2-specific CAR-NK	7
Correction to: YAP1 acts as a negative regulator of pro-tumor TAZ expression in esophageal squamous cell carcinoma	6
Targeting tumor associated macrophages (TAMs) reprograms tumor immune microenvironment to promote solid tumor immunotherapy	6
ONECUT2 is a druggable driver of luminal to basal breast cancer plasticity	6
Effect of neoadjuvant targeted therapy on the tumor microenvironment in resectable lung adenocarcinoma	6
BHLHE41, a transcriptional repressor involved in physiological processes and tumor development	6
Genomic copy number alterations as biomarkers for triple negative pregnancy-associated breast cancer	6
Perineural invasion in colorectal cancer: mechanisms of action and clinical relevance	6
Inhibition of the bromodomain and extra-terminal family of epigenetic regulators as a promising therapeutic approach for gastric cancer	6
Clinical value of 18F-FDG PET/CT in patients with newly diagnosed acute leukemia	6
Immunosuppression, immune escape, and immunotherapy in pancreatic cancer: focused on the tumor microenvironment	6
The prognostic effect of tumor-associated macrophages in stage I-III colorectal cancer depends on T cell infiltration	6
OrBITS: label-free and time-lapse monitoring of patient derived organoids for advanced drug screening	6
Fibroblast-derived PI16 enhances tumor immune-suppressive microenvironment via inducing Tregs differentiation	6
AKT-driven epithelial-mesenchymal transition is affected by copper bioavailability in HER2 negative breast cancer cells via a LOXL2-independent mechanism	6
TENT5A mediates the cancer-inhibiting effects of EGR1 by suppressing the protein stability of RPL35 in hepatocellular carcinoma	6
FAP is a prognostic marker, but not a viable therapeutic target for clinical translation in HNSCC	6
DNA repair in tumor radioresistance: insights from fruit flies genetics	6
Dexmedetomidine promotes colorectal cancer progression via Piwil2 signaling	6
The leukemia inhibitory factor regulates fibroblast growth factor receptor 4 transcription in gastric cancer	6
Loss of USP28 and SPINT2 expression promotes cancer cell survival after whole genome doubling	6
Toxicity profiles of immunochemotherapy for gastric or gastroesophageal junction adenocarcinoma: a systematic review and meta-analysis	6
Role of BRCA1 in glioblastoma etiology	6
Hepatocyte nuclear factor 4-Alpha: a key regulator in liver carcinogenesis	6
The role of tumor-platelet interplay and micro tumor thrombi during hematogenous tumor metastasis	6
CAFs mediate carboplatin resistance in LUAD via CXCL12 secretion regulated by NF-κB activation	6
ACSM3 suppresses the pathogenesis of high-grade serous ovarian carcinoma via promoting AMPK activity	6
Cell signaling activation and extracellular matrix remodeling underpin glioma tumor microenvironment heterogeneity and organization	6
The microbiota and renal cell carcinoma	5
CAFs vs. TECs: when blood feuds fuel cancer progression, dissemination and therapeutic resistance	5
Cancer-associated fibroblast miR-148a-5p/CALD1/collagen VI pathway promotes proliferation in Helicobacter pylori-positive gastric cancer	5
Direct knockdown of phospho-PTM targets mediated by TRIM21 can improve personalized treatment in breast cancer	5
Targeted gene delivery systems for T-cell engineering	5
Blockade of USP14 potentiates type I interferon signaling and radiation-induced antitumor immunity via preventing IRF3 deubiquitination	5
Distinct expression and function of breast cancer metastasis suppressor 1 in mutant P53 glioblastoma	5
Exosomes delivering miR-129-5p combined with sorafenib ameliorate hepatocellular carcinoma progression via the KCTD1/HIF-1α/VEGF pathway	5
Sirtuin 5-mediated deacetylation of TAZ at K54 promotes melanoma development	5
Molecular actions of exosomes and their theragnostics in colorectal cancer: current findings and limitations	5
Calcium acts as a central player in melatonin antitumor activity in sarcoma cells	5
SS18-SSX drives CREB activation in synovial sarcoma	5
Novel preclinical gastroenteropancreatic neuroendocrine neoplasia models demonstrate the feasibility of mutation-based targeted therapy	5
Correction: Targeting ARHGEF12 promotes neuroblastoma differentiation, MYCN degradation, and reduces tumorigenicity	5
A novel pyroptosis-associated lncRNA LINC01133 promotes pancreatic adenocarcinoma development via miR-30b-5p/SIRT1 axis	5
Hedgehog ligand and receptor cooperatively regulate EGFR stability and activity in non-small cell lung cancer	5
Establishment of experimental salivary gland cancer models using organoid culture and patient-derived xenografting	5
Ferritinophagy induced ferroptosis in the management of cancer	5
Omics-based molecular classifications empowering in precision oncology	5
A diagnostic model based on transcriptomic analysis reveals inflammation as a potential prognosis factor for hepatoblastoma with hepatocellular carcinoma features	5
Targeted CRISPR activation and knockout screenings identify novel doxorubicin transporters	5
The negative effect of G1958A polymorphism on MTHFD1 protein stability and HCC growth	5